The Network Advantage
Making the case for consolidation and consistency in clinical trials
What do sponsors and CROs really think about MCRCs?
AMRC’s latest research, run in collaboration with SBM Research, investigated how Sponsors and CROs perceive the multisite clinical research corporation model.
The findings revealed a consistent gap: MCRCs are recognized for operational strengths like consistency, faster start-up, scalable infrastructure, and access to diverse patient populations, but are not consistently rated as the highest-quality providers of clinical research.
This report sets out those findings and asks, why aren’t MCRCs the default choice?
